Amélia Catarina Fernandes Soares Vieira

Dr. Amélia Catarina Fernandes Soares Vieira

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2025 in Sustainable Chemistry and Pharmacy
Verified
Journal Article
Open access
BCBeatriz Couceiro
Beatriz Couceiro
HHHuma Hameed
Huma Hameed
Amélia Catarina Fernandes Soares VieiraAmélia Catarina Fernandes Soares Vieira
Amélia Catarina Fernandes Soares Vieira
SSSachin Kumar Singh
Sachin Kumar Singh
KDKamal Dua
Kamal Dua
Ana Cláudia Paiva-SantosAna Cláudia Paiva-Santos
Ana Cláudia Paiva-Santos

1 April 2013 in Carbohydrate Polymers
Verified
Journal Article
Closed access
Amélia Catarina Fernandes Soares VieiraAmélia Catarina Fernandes Soares Vieira
Amélia Catarina Fernandes Soares Vieira
ASArmenio Serra
Armenio Serra
RCRui A. Carvalho
Rui A. Carvalho
AGAlexandra Gonsalves
Alexandra Gonsalves
AFAna Figueiras
Ana Figueiras
AGAntónio M. D’a. Rocha Gonsalves
António M. D’a. Rocha Gonsalves

26 February 2025 in Bioengineering & Translational Medicine
Verified
Journal Article
Open access
JLJoana Lopes
Joana Lopes
DLDaniela Lopes
Daniela Lopes
MMMahzad Motallebi
Mahzad Motallebi
MYMengguang Ye
Mengguang Ye
YXYuxiang Xue
Yuxiang Xue
Pooyan MakvandiPooyan Makvandi
Pooyan Makvandi
Gastrointestinal cancers, a major global cause of cancer‐related mortality and disease burden, are a heterogeneous group of malignant aliments involving different organs of the digestive system. The late clinical diagnosis, genomic tumor heterogeneity, high complexity of the gastrointestinal tumor microenvironment, along with increasing treatment resistance have been recognized as the main contributing factors to the current inadequacy of the clinical interventions and poor prognosis of the gastrointestinal cancer patients. In the coming years, gastrointestinal cancer‐related global mortality is unfortunately predicted to increase due to the absence of early detection and effective therapeutic options. Biomembrane‐coated biomimetic nanoparticles (NPs) have recently been appointed as advanced nanotechnological tools for the clinical management of gastrointestinal cancers. These comprise not only cell‐mimicking nanodevices (the pioneers of this top‐down coating technology), but also exosome and bacterial mimetics. Due to their enhanced bio‐interfacing features, biocompatibility, immune evasion, and specific targetability to tumorous tissues, these biomimetic nanostructures have been successfully exploited to provide safer, effective, and targeted gastrointestinal cancer applications. This review highlights the latest research on biomembrane‐coated nanosystems for the clinical therapy and diagnosis of the most common and deadliest subtypes of gastrointestinal cancers, namely colorectal cancer, gastric cancer, liver cancer, esophageal cancer, and pancreatic cancer. The current challenges toward their clinical translation are also mentioned.

1 March 2016 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
Amélia Catarina Fernandes Soares VieiraAmélia Catarina Fernandes Soares Vieira
Amélia Catarina Fernandes Soares Vieira
ASArmenio Serra
Armenio Serra
Francisco VeigaFrancisco Veiga
Francisco Veiga
AGAntónio M.D’a Rocha Gonsalves
António M.D’a Rocha Gonsalves
ABAbdul W. Basit
Abdul W. Basit
SMSudaxshina Murdan
Sudaxshina Murdan
The aim of this in vivo study was to assess the ability of the prodrug conjugate diclofenac-β-cyclodextrin to release diclofenac in the colon following oral administration, using sulfapyridine (a metabolite of sulfasalazine) as a marker of colonic absorption. Two groups of rats were used; the test rats received a suspension containing the two prodrugs, diclofenac-β-cyclodextrin and sulfasalazine, while the control rats received a suspension containing the corresponding free drugs, sodium diclofenac and sulfapyridine. The rats were fasted overnight with free access to water before and throughout the first 12h of the study. Blood was collected from the tail vein at pre-determined time points and the plasma analyzed for the concentrations of diclofenac and sulfapyridine. Following the oral administration of the two prodrugs, a more extended absorption profile was observed and Cmax was achieved 10h post-dose, in contrast to rapid absorption of the free drugs (tmax of diclofenac being 1.3h, and that of sulfapyridine being 2.1h). In addition to a later tmax, conjugation of diclofenac to β-cyclodextrin also resulted in a reduced Cmax and a reduced AUC. The same tmax for diclofenac-β-cyclodextrin as for sulfasalazine confirms the colonic metabolism of diclofenac-β-cyclodextrin. This study shows the potential of this new cyclodextrin-based prodrug to target and release diclofenac specifically in the colon following oral administration.

1 March 2008 in American Journal of Agricultural and Biological Sciences
Verified
Journal Article
Open access
PDF file
NANorma Almaraz-Abarca
Norma Almaraz-Abarca
Maria Graça CamposMaria Graça Campos
Maria Graça Campos
EDElí A. Delgado-Alvarado
Elí A. Delgado-Alvarado
JÁJosé A. Ávila-Reyes
José A. Ávila-Reyes
JHJesús Herrera-Corral
Jesús Herrera-Corral
JUJose N. Uribe-Soto
Jose N. Uribe-Soto
The pollen flavonoid/phenolic acid composition of 14 individual of Stenocactus multicostatus subsp. zacatecasensis (Britton et Rose) U. Guzmán et Vázquez-Benitez, comb. et stat. nov., 11 of Echinocereus enneacanthus Engelmann, 8 of Echinocereus pectinatus (Scheidweiler) Engelmann and 12 of Mammillaria heyderi sensu lato (all belonging to Cactaceae) was analyzed by HPLC/DAD with the aim of determining the role of pollen profiles of flavonoid/phenolic acid as valuable markers in those taxa. The flavonoid/phenolic acid composition of pollen was evaluated within and among the taxa analyzed. The results suggest that (a) the flavonoid/phenolic acid profiles of these species are among the most complex reported, (b) that quercetin, kaempferol and herbacetin glycoside derivatives are the major phenols found in the pollen of these species of cactus, (c) that some intrapopulation variability is present in all four species and (d) that these pollen flavonoid/phenolic acid profiles tend to be species-specific, so that they can represent important taxonomic markers in Cactaceae.

26 November 2025 in Drug Delivery and Translational Research
Verified
Journal Article
Closed access
PDF file
PFPatrícia Ferreira
Patrícia Ferreira
JAJanaina Ataide
Janaina Ataide
SBSoraya Babaie
Soraya Babaie
Amélia Catarina Fernandes Soares VieiraAmélia Catarina Fernandes Soares Vieira
Amélia Catarina Fernandes Soares Vieira
Gustavo CostaGustavo Costa
Gustavo Costa
Ana Cláudia Paiva-SantosAna Cláudia Paiva-Santos
Ana Cláudia Paiva-Santos
1